Scinovex
articleTop 1% cited

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Nature Medicine · 2007 · Vol. 13(9) · pp. 1050–1059
Lionel ApétohFrançois GhiringhelliAntoine TesnièreMichel ObéidCarla OrtizAlfredo CriolloGrégoire MignotMaria Chiara MaiuriEvelyn UllrichPatrick SaulnierHuan YangSebastián AmigorenaBernard RyffelFranck J. BarratPaul SäftigFrançis LéviRosette LidereauCatherine NoguèsJean‐Paul MiraAgnès ChompretV. JoulinFrançoise Clavel‐ChapelonJean BourhisFabrice AndréSuzette DelalogeThomas TurszGuido KroemerLaurence Zitvogel
Immune Response and InflammationImmunotherapy and Immune ResponsesImmune Cell Function and InteractionImmunogenic cell deathImmunoadjuvantRadiation therapyImmune systemCancer researchToll-like receptorHMGB1Acquired immune systemTLR4Immunotherapy

MeSH terms

AnimalsAntineoplastic AgentsBone NeoplasmsColonic NeoplasmsDisease Models, AnimalHumansMice, Inbred BALB CNeoplasmsOrganoplatinum CompoundsPyridinesOsteosarcomaCell Line, TumorToll-Like Receptor 4Mice
Citations
2,933
FWCI
40.35
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.